HUS1500004I1 - Phospholipid gel compositions for drug delivery and methods of treating conditions using same - Google Patents
Phospholipid gel compositions for drug delivery and methods of treating conditions using sameInfo
- Publication number
- HUS1500004I1 HUS1500004I1 HUS1500004C HUS1500004C HUS1500004I1 HU S1500004 I1 HUS1500004 I1 HU S1500004I1 HU S1500004 C HUS1500004 C HU S1500004C HU S1500004 C HUS1500004 C HU S1500004C HU S1500004 I1 HUS1500004 I1 HU S1500004I1
- Authority
- HU
- Hungary
- Prior art keywords
- methods
- same
- drug delivery
- treating conditions
- gel compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/874,532 US7854943B2 (en) | 2004-06-24 | 2004-06-24 | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
EP05766244A EP1781256B1 (en) | 2004-06-24 | 2005-06-23 | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
PCT/US2005/022072 WO2006012145A1 (en) | 2004-06-24 | 2005-06-23 | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
Publications (1)
Publication Number | Publication Date |
---|---|
HUS1500004I1 true HUS1500004I1 (en) | 2017-09-28 |
Family
ID=35506068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUS1500004C HUS1500004I1 (en) | 2004-06-24 | 2015-01-29 | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
Country Status (3)
Country | Link |
---|---|
US (1) | US7854943B2 (en) |
CN (1) | CN101014323B (en) |
HU (1) | HUS1500004I1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US8017159B2 (en) * | 2005-11-16 | 2011-09-13 | Idexx Laboratories, Inc. | Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
WO2008021367A2 (en) | 2006-08-11 | 2008-02-21 | President And Fellows Of Harvard College | Moenomycin biosynthesis-related compositions and methods of use thereof |
US8604004B2 (en) * | 2007-10-04 | 2013-12-10 | President And Fellows Of Harvard College | Moenomycin analogs, methods of synthesis, and uses thereof |
WO2010033726A2 (en) | 2008-09-17 | 2010-03-25 | The Brigham And Women's Hospital, Inc. | Drug delivery composition comprising a self-assembled gelator |
EP2618821A4 (en) | 2010-09-24 | 2014-08-13 | Brigham & Womens Hospital | Nanostructured gels capable of controlled release of encapsulated agents |
EP2850090B1 (en) | 2012-04-06 | 2018-10-03 | President and Fellows of Harvard College | Chemoenzymatic methods for synthesizing moenomycin analogs |
US9273084B2 (en) | 2012-04-06 | 2016-03-01 | President And Fellows Of Harvard College | Moenomycin analogs, methods of synthesis, and uses thereof |
EP2850091A1 (en) | 2012-04-06 | 2015-03-25 | President and Fellows of Harvard College | Methods and compounds for identifying glycosyltransferase inhibitors |
GB201511058D0 (en) * | 2015-06-23 | 2015-08-05 | Lamellar Biomedical Ltd | Compositions and methods for using lamellar bodies for therapeutic purposes |
CN115837006A (en) | 2016-05-06 | 2023-03-24 | 布里格姆及妇女医院股份有限公司 | Binary self-assembling gels for controlled delivery of encapsulated agents into cartilage |
WO2018144991A1 (en) | 2017-02-03 | 2018-08-09 | The Brigham And Women's Hospital, Inc. | Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof |
EP3621594A1 (en) * | 2017-05-08 | 2020-03-18 | Alivio Therapeutics, Inc. | Formulation of nanostructured gels for increased agent loading and adhesion |
CA3113948A1 (en) | 2018-10-11 | 2020-04-16 | Alivio Therapeutics, Inc. | Non-injectable hydrogel formulations for smart release |
US20230158050A1 (en) * | 2020-04-28 | 2023-05-25 | Institute Of Rheological Function Of Food Co., Ltd. | Composition for enhancing immune function |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909466A (en) * | 1956-05-29 | 1959-10-20 | Pfizer & Co C | Stable solutions of oxytetracycline salts |
US4025620A (en) * | 1975-10-22 | 1977-05-24 | Leo Pharmaceutical Products Ltd., A/S | Treatment of canine otitis and composition therefor |
JPS536426A (en) * | 1976-07-06 | 1978-01-20 | Bayer Ag | Antibiotic agent |
IE53610B1 (en) | 1981-12-14 | 1988-12-21 | Merck & Co Inc | Waterless thixotropic composition |
JPS6087215A (en) | 1983-10-19 | 1985-05-16 | Mitsui Toatsu Chem Inc | Base of drug for external use |
FR2570602B1 (en) * | 1984-09-21 | 1986-11-28 | Cird | PHARMACEUTICAL VEHICLE FOR ACTIVE SUBSTANCES IN THE FORM OF ANHYDROUS GEL |
US4678516A (en) * | 1984-10-09 | 1987-07-07 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
US4837008A (en) * | 1985-04-09 | 1989-06-06 | Peroxydent Group | Periodontal composition and method |
US4843096A (en) * | 1985-06-26 | 1989-06-27 | Stiefel Laboratories, Inc. | Treatment of acne |
US4847267A (en) * | 1986-03-17 | 1989-07-11 | Charles Of The Ritz Group Ltd. | Skin treatment composition and method |
US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
US4814173A (en) * | 1987-09-08 | 1989-03-21 | Warner-Lambert Company | Silicone elastomer transdermal matrix system |
US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5110809A (en) * | 1988-03-21 | 1992-05-05 | Bristol-Myers Squibb Company | Antifungal gel formulations |
KR920703033A (en) * | 1990-11-09 | 1992-12-17 | 아카자와 소조 | External preparations containing procaterol |
US6005001A (en) * | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
HU223343B1 (en) | 1991-05-20 | 2004-06-28 | Novartis Ag. | Compositions comprising allylamine derivatives, and process for their preparation |
DE4200821A1 (en) * | 1992-01-15 | 1993-07-22 | Bayer Ag | TASTE-MASKED PHARMACEUTICAL AGENTS |
US5656355A (en) * | 1992-03-12 | 1997-08-12 | Kimberly-Clark Corporation | Multilayer elastic metallized material |
AU674684B2 (en) * | 1992-07-20 | 1997-01-09 | Sterno Group LLC, The | Gelled organic liquids |
US5631004A (en) * | 1993-09-30 | 1997-05-20 | Alcon Laboratories, Inc. | Use of sustained release antibiotic compositions in ophthalmic surgical procedures |
US5516808A (en) * | 1994-10-27 | 1996-05-14 | Sawaya; Assad S. | Topical cellulose pharmaceutical formulation |
US5849761A (en) * | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
WO1998006407A1 (en) * | 1996-07-30 | 1998-02-19 | Ashmont Holdings Limited | Anthelmintic formulations |
DK0949905T3 (en) * | 1996-12-20 | 2001-10-22 | Alza Corp | Injectable depot preparation and method of preparation |
US6630168B1 (en) * | 1997-02-20 | 2003-10-07 | Biomedicines, Inc. | Gel delivery vehicles for anticellular proliferative agents |
US6018033A (en) * | 1997-05-13 | 2000-01-25 | Purdue Research Foundation | Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same |
AU1827799A (en) * | 1997-12-15 | 1999-07-05 | Axia Therapeutics, Inc. | Oral delivery formulation |
US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
US6436455B2 (en) * | 1998-06-15 | 2002-08-20 | General Mills, Inc. | Multi-colored aerated confectionery products |
US6146664A (en) * | 1998-07-10 | 2000-11-14 | Shaklee Corporation | Stable topical ascorbic acid compositions |
GB2340751B (en) | 1998-08-12 | 2003-11-05 | Edko Trading Representation | Pharmaceutical compositions |
US6238683B1 (en) * | 1998-12-04 | 2001-05-29 | Johnson & Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US7919119B2 (en) * | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US6214339B1 (en) * | 2000-01-12 | 2001-04-10 | Michael A. Pellico | Di-enzymatic treatment of outer ear infection in dogs and cats |
US6565873B1 (en) * | 2000-10-25 | 2003-05-20 | Salvona Llc | Biodegradable bioadhesive controlled release system of nano-particles for oral care products |
US6787568B1 (en) * | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
EP1446103B1 (en) | 2001-10-19 | 2015-12-23 | Idexx Laboratories, Inc. | Injectable compositions for the controlled delivery of pharmacologically active compound |
EP1567113A4 (en) * | 2002-10-24 | 2006-11-08 | G & R Pharmaceuticals Llc | Antifungal formulations |
US7718189B2 (en) * | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
US20040197408A1 (en) * | 2002-12-30 | 2004-10-07 | Angiotech International Ag | Amino acids in micelle preparation |
US20040220264A1 (en) * | 2003-03-17 | 2004-11-04 | Yu Ruey J | Bioavailability and improved delivery of acidic pharmaceutical drugs |
US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
US20050009931A1 (en) * | 2003-03-20 | 2005-01-13 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
WO2004082588A2 (en) * | 2003-03-20 | 2004-09-30 | Pharmacia Corporation | Dispersible formulation of an anti-inflammatory agent |
WO2004093870A1 (en) * | 2003-03-20 | 2004-11-04 | Pharmacia Corporation | Treatment and prevention of otic disorders |
US8003616B2 (en) * | 2004-04-23 | 2011-08-23 | Albert Rory J | Composition for the treatment of ear infections and method |
US7618651B2 (en) * | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
-
2004
- 2004-06-24 US US10/874,532 patent/US7854943B2/en active Active
-
2005
- 2005-06-23 CN CN2005800285700A patent/CN101014323B/en active Active
-
2015
- 2015-01-29 HU HUS1500004C patent/HUS1500004I1/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20050287198A1 (en) | 2005-12-29 |
US7854943B2 (en) | 2010-12-21 |
CN101014323B (en) | 2012-09-05 |
CN101014323A (en) | 2007-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1781256A4 (en) | Phospholipid gel compositions for drug delivery and methods of treating conditions using same | |
HUS1500004I1 (en) | Phospholipid gel compositions for drug delivery and methods of treating conditions using same | |
SI1765293T1 (en) | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same | |
EP1804832A4 (en) | Methods and compositions for needleless delivery of macromolecules | |
IL176108A0 (en) | Methods and dosage forms for increasing solubility of drug compositions for controlled delivery | |
EP2012864A4 (en) | Apparatus and method for delivery of therapeutic and other types of agents | |
HK1109062A1 (en) | Compositions and methods of use for treatment of mammalian diseases | |
IL179515A0 (en) | Method of administering and using vegf inhibitors for the treatment of human cancer | |
EP2007398A4 (en) | High delivery rates for lipid based drug formulations, and methods of treatment thereof | |
IL180517A0 (en) | Novel statin pharmaceutical compositions and related methods of treatment | |
EP1848270A4 (en) | Transmucosal administration of drug compositions for treating and preventing disorders in animals | |
IL174627A0 (en) | Compositions and methods for treatment of burns | |
ZA200705750B (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
EP1615621A4 (en) | Compositions for delivery of drug combinations | |
EP1631270A4 (en) | Methods and compositions for delivery of catecholic butanes for treatment of diseases | |
EP1773369A4 (en) | Pharmaceutical compositions and methods for peptide treatment | |
EP1648474A4 (en) | Methods and pharmaceutical compositions for healing wounds | |
IL173148A0 (en) | Methods and pharmaceutical compositions for healing wounds | |
EP1720563A4 (en) | Methods and compositions for the treatment of inflammation | |
GB0404327D0 (en) | Pharmaceutical composition and method of using same | |
EP1773349A4 (en) | Methods and compositions for treatment of preeclampsia | |
EP1667656A4 (en) | Compositions and methods for delivery of biologically active agents | |
IL178636A0 (en) | Compositions and methods for therapy of chemotherapy-induced neuropathy | |
EP1633328A4 (en) | Method and composition for stable and controlled delivery of (-)-hydroxycitric acid | |
HK1104800A1 (en) | Method of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases |